The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Peptide Synthesis CMO Market Research Report 2025

Global Peptide Synthesis CMO Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1680887

No of Pages : 92

Synopsis
Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

The global Peptide Synthesis CMO market was valued at US$ 2686.3 million in 2023 and is anticipated to reach US$ 7322.2 million by 2030, witnessing a CAGR of 15.0% during the forecast period 2024-2030.

The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.

This report aims to provide a comprehensive presentation of the global market for Peptide Synthesis CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Synthesis CMO.

Report Scope

The Peptide Synthesis CMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Synthesis CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Synthesis CMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Bachem

PolyPeptide

USV Peptides

Thermofischer

Bio Basic

JPT

Genscript

Xinbang Pharma

ScinoPharm

AmbioPharm

SN Biopharm

CBL

Piramal Pharma

CordenPharma

CPC Scientific

Segment by Type

APIs and Intermediates

FDF

Segment by Application

Commercial

Academic Research

Other

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide Synthesis CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide Synthesis CMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 APIs and Intermediates

1.2.3 FDF

1.3 Market by Application

1.3.1 Global Peptide Synthesis CMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Commercial

1.3.3 Academic Research

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide Synthesis CMO Market Perspective (2019-2030)

2.2 Peptide Synthesis CMO Growth Trends by Region

2.2.1 Global Peptide Synthesis CMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Peptide Synthesis CMO Historic Market Size by Region (2019-2024)

2.2.3 Peptide Synthesis CMO Forecasted Market Size by Region (2025-2030)

2.3 Peptide Synthesis CMO Market Dynamics

2.3.1 Peptide Synthesis CMO Industry Trends

2.3.2 Peptide Synthesis CMO Market Drivers

2.3.3 Peptide Synthesis CMO Market Challenges

2.3.4 Peptide Synthesis CMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide Synthesis CMO Players by Revenue

3.1.1 Global Top Peptide Synthesis CMO Players by Revenue (2019-2024)

3.1.2 Global Peptide Synthesis CMO Revenue Market Share by Players (2019-2024)

3.2 Global Peptide Synthesis CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Peptide Synthesis CMO Revenue

3.4 Global Peptide Synthesis CMO Market Concentration Ratio

3.4.1 Global Peptide Synthesis CMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide Synthesis CMO Revenue in 2023

3.5 Peptide Synthesis CMO Key Players Head office and Area Served

3.6 Key Players Peptide Synthesis CMO Product Solution and Service

3.7 Date of Enter into Peptide Synthesis CMO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Synthesis CMO Breakdown Data by Type

4.1 Global Peptide Synthesis CMO Historic Market Size by Type (2019-2024)

4.2 Global Peptide Synthesis CMO Forecasted Market Size by Type (2025-2030)

5 Peptide Synthesis CMO Breakdown Data by Application

5.1 Global Peptide Synthesis CMO Historic Market Size by Application (2019-2024)

5.2 Global Peptide Synthesis CMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Peptide Synthesis CMO Market Size (2019-2030)

6.2 North America Peptide Synthesis CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Peptide Synthesis CMO Market Size by Country (2019-2024)

6.4 North America Peptide Synthesis CMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide Synthesis CMO Market Size (2019-2030)

7.2 Europe Peptide Synthesis CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Peptide Synthesis CMO Market Size by Country (2019-2024)

7.4 Europe Peptide Synthesis CMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide Synthesis CMO Market Size (2019-2030)

8.2 Asia-Pacific Peptide Synthesis CMO Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Peptide Synthesis CMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Peptide Synthesis CMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide Synthesis CMO Market Size (2019-2030)

9.2 Latin America Peptide Synthesis CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Peptide Synthesis CMO Market Size by Country (2019-2024)

9.4 Latin America Peptide Synthesis CMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide Synthesis CMO Market Size (2019-2030)

10.2 Middle East & Africa Peptide Synthesis CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Peptide Synthesis CMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Peptide Synthesis CMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bachem

11.1.1 Bachem Company Detail

11.1.2 Bachem Business Overview

11.1.3 Bachem Peptide Synthesis CMO Introduction

11.1.4 Bachem Revenue in Peptide Synthesis CMO Business (2019-2024)

11.1.5 Bachem Recent Development

11.2 PolyPeptide

11.2.1 PolyPeptide Company Detail

11.2.2 PolyPeptide Business Overview

11.2.3 PolyPeptide Peptide Synthesis CMO Introduction

11.2.4 PolyPeptide Revenue in Peptide Synthesis CMO Business (2019-2024)

11.2.5 PolyPeptide Recent Development

11.3 USV Peptides

11.3.1 USV Peptides Company Detail

11.3.2 USV Peptides Business Overview

11.3.3 USV Peptides Peptide Synthesis CMO Introduction

11.3.4 USV Peptides Revenue in Peptide Synthesis CMO Business (2019-2024)

11.3.5 USV Peptides Recent Development

11.4 Thermofischer

11.4.1 Thermofischer Company Detail

11.4.2 Thermofischer Business Overview

11.4.3 Thermofischer Peptide Synthesis CMO Introduction

11.4.4 Thermofischer Revenue in Peptide Synthesis CMO Business (2019-2024)

11.4.5 Thermofischer Recent Development

11.5 Bio Basic

11.5.1 Bio Basic Company Detail

11.5.2 Bio Basic Business Overview

11.5.3 Bio Basic Peptide Synthesis CMO Introduction

11.5.4 Bio Basic Revenue in Peptide Synthesis CMO Business (2019-2024)

11.5.5 Bio Basic Recent Development

11.6 JPT

11.6.1 JPT Company Detail

11.6.2 JPT Business Overview

11.6.3 JPT Peptide Synthesis CMO Introduction

11.6.4 JPT Revenue in Peptide Synthesis CMO Business (2019-2024)

11.6.5 JPT Recent Development

11.7 Genscript

11.7.1 Genscript Company Detail

11.7.2 Genscript Business Overview

11.7.3 Genscript Peptide Synthesis CMO Introduction

11.7.4 Genscript Revenue in Peptide Synthesis CMO Business (2019-2024)

11.7.5 Genscript Recent Development

11.8 Xinbang Pharma

11.8.1 Xinbang Pharma Company Detail

11.8.2 Xinbang Pharma Business Overview

11.8.3 Xinbang Pharma Peptide Synthesis CMO Introduction

11.8.4 Xinbang Pharma Revenue in Peptide Synthesis CMO Business (2019-2024)

11.8.5 Xinbang Pharma Recent Development

11.9 ScinoPharm

11.9.1 ScinoPharm Company Detail

11.9.2 ScinoPharm Business Overview

11.9.3 ScinoPharm Peptide Synthesis CMO Introduction

11.9.4 ScinoPharm Revenue in Peptide Synthesis CMO Business (2019-2024)

11.9.5 ScinoPharm Recent Development

11.10 AmbioPharm

11.10.1 AmbioPharm Company Detail

11.10.2 AmbioPharm Business Overview

11.10.3 AmbioPharm Peptide Synthesis CMO Introduction

11.10.4 AmbioPharm Revenue in Peptide Synthesis CMO Business (2019-2024)

11.10.5 AmbioPharm Recent Development

11.11 SN Biopharm

11.11.1 SN Biopharm Company Detail

11.11.2 SN Biopharm Business Overview

11.11.3 SN Biopharm Peptide Synthesis CMO Introduction

11.11.4 SN Biopharm Revenue in Peptide Synthesis CMO Business (2019-2024)

11.11.5 SN Biopharm Recent Development

11.12 CBL

11.12.1 CBL Company Detail

11.12.2 CBL Business Overview

11.12.3 CBL Peptide Synthesis CMO Introduction

11.12.4 CBL Revenue in Peptide Synthesis CMO Business (2019-2024)

11.12.5 CBL Recent Development

11.13 Piramal Pharma

11.13.1 Piramal Pharma Company Detail

11.13.2 Piramal Pharma Business Overview

11.13.3 Piramal Pharma Peptide Synthesis CMO Introduction

11.13.4 Piramal Pharma Revenue in Peptide Synthesis CMO Business (2019-2024)

11.13.5 Piramal Pharma Recent Development

11.14 CordenPharma

11.14.1 CordenPharma Company Detail

11.14.2 CordenPharma Business Overview

11.14.3 CordenPharma Peptide Synthesis CMO Introduction

11.14.4 CordenPharma Revenue in Peptide Synthesis CMO Business (2019-2024)

11.14.5 CordenPharma Recent Development

11.15 CPC Scientific

11.15.1 CPC Scientific Company Detail

11.15.2 CPC Scientific Business Overview

11.15.3 CPC Scientific Peptide Synthesis CMO Introduction

11.15.4 CPC Scientific Revenue in Peptide Synthesis CMO Business (2019-2024)

11.15.5 CPC Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Peptide Synthesis CMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of APIs and Intermediates

Table 3. Key Players of FDF

Table 4. Global Peptide Synthesis CMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Peptide Synthesis CMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Peptide Synthesis CMO Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Peptide Synthesis CMO Market Share by Region (2019-2024)

Table 8. Global Peptide Synthesis CMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Peptide Synthesis CMO Market Share by Region (2025-2030)

Table 10. Peptide Synthesis CMO Market Trends

Table 11. Peptide Synthesis CMO Market Drivers

Table 12. Peptide Synthesis CMO Market Challenges

Table 13. Peptide Synthesis CMO Market Restraints

Table 14. Global Peptide Synthesis CMO Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Peptide Synthesis CMO Market Share by Players (2019-2024)

Table 16. Global Top Peptide Synthesis CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Synthesis CMO as of 2023)

Table 17. Ranking of Global Top Peptide Synthesis CMO Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Peptide Synthesis CMO Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Peptide Synthesis CMO Product Solution and Service

Table 21. Date of Enter into Peptide Synthesis CMO Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peptide Synthesis CMO Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Peptide Synthesis CMO Revenue Market Share by Type (2019-2024)

Table 25. Global Peptide Synthesis CMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Peptide Synthesis CMO Revenue Market Share by Type (2025-2030)

Table 27. Global Peptide Synthesis CMO Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Peptide Synthesis CMO Revenue Market Share by Application (2019-2024)

Table 29. Global Peptide Synthesis CMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Peptide Synthesis CMO Revenue Market Share by Application (2025-2030)

Table 31. North America Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Peptide Synthesis CMO Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Peptide Synthesis CMO Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Peptide Synthesis CMO Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Peptide Synthesis CMO Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Peptide Synthesis CMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Peptide Synthesis CMO Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Peptide Synthesis CMO Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Peptide Synthesis CMO Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Peptide Synthesis CMO Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Peptide Synthesis CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Peptide Synthesis CMO Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Peptide Synthesis CMO Market Size by Country (2025-2030) & (US$ Million)

Table 46. Bachem Company Detail

Table 47. Bachem Business Overview

Table 48. Bachem Peptide Synthesis CMO Product

Table 49. Bachem Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 50. Bachem Recent Development

Table 51. PolyPeptide Company Detail

Table 52. PolyPeptide Business Overview

Table 53. PolyPeptide Peptide Synthesis CMO Product

Table 54. PolyPeptide Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 55. PolyPeptide Recent Development

Table 56. USV Peptides Company Detail

Table 57. USV Peptides Business Overview

Table 58. USV Peptides Peptide Synthesis CMO Product

Table 59. USV Peptides Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 60. USV Peptides Recent Development

Table 61. Thermofischer Company Detail

Table 62. Thermofischer Business Overview

Table 63. Thermofischer Peptide Synthesis CMO Product

Table 64. Thermofischer Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 65. Thermofischer Recent Development

Table 66. Bio Basic Company Detail

Table 67. Bio Basic Business Overview

Table 68. Bio Basic Peptide Synthesis CMO Product

Table 69. Bio Basic Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 70. Bio Basic Recent Development

Table 71. JPT Company Detail

Table 72. JPT Business Overview

Table 73. JPT Peptide Synthesis CMO Product

Table 74. JPT Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 75. JPT Recent Development

Table 76. Genscript Company Detail

Table 77. Genscript Business Overview

Table 78. Genscript Peptide Synthesis CMO Product

Table 79. Genscript Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 80. Genscript Recent Development

Table 81. Xinbang Pharma Company Detail

Table 82. Xinbang Pharma Business Overview

Table 83. Xinbang Pharma Peptide Synthesis CMO Product

Table 84. Xinbang Pharma Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 85. Xinbang Pharma Recent Development

Table 86. ScinoPharm Company Detail

Table 87. ScinoPharm Business Overview

Table 88. ScinoPharm Peptide Synthesis CMO Product

Table 89. ScinoPharm Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 90. ScinoPharm Recent Development

Table 91. AmbioPharm Company Detail

Table 92. AmbioPharm Business Overview

Table 93. AmbioPharm Peptide Synthesis CMO Product

Table 94. AmbioPharm Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 95. AmbioPharm Recent Development

Table 96. SN Biopharm Company Detail

Table 97. SN Biopharm Business Overview

Table 98. SN Biopharm Peptide Synthesis CMO Product

Table 99. SN Biopharm Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 100. SN Biopharm Recent Development

Table 101. CBL Company Detail

Table 102. CBL Business Overview

Table 103. CBL Peptide Synthesis CMO Product

Table 104. CBL Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 105. CBL Recent Development

Table 106. Piramal Pharma Company Detail

Table 107. Piramal Pharma Business Overview

Table 108. Piramal Pharma Peptide Synthesis CMO Product

Table 109. Piramal Pharma Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 110. Piramal Pharma Recent Development

Table 111. CordenPharma Company Detail

Table 112. CordenPharma Business Overview

Table 113. CordenPharma Peptide Synthesis CMO Product

Table 114. CordenPharma Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 115. CordenPharma Recent Development

Table 116. CPC Scientific Company Detail

Table 117. CPC Scientific Business Overview

Table 118. CPC Scientific Peptide Synthesis CMO Product

Table 119. CPC Scientific Revenue in Peptide Synthesis CMO Business (2019-2024) & (US$ Million)

Table 120. CPC Scientific Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Peptide Synthesis CMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Peptide Synthesis CMO Market Share by Type: 2023 VS 2030

Figure 3. APIs and Intermediates Features

Figure 4. FDF Features

Figure 5. Global Peptide Synthesis CMO Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Peptide Synthesis CMO Market Share by Application: 2023 VS 2030

Figure 7. Commercial Case Studies

Figure 8. Academic Research Case Studies

Figure 9. Other Case Studies

Figure 10. Peptide Synthesis CMO Report Years Considered

Figure 11. Global Peptide Synthesis CMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Peptide Synthesis CMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Peptide Synthesis CMO Market Share by Region: 2023 VS 2030

Figure 14. Global Peptide Synthesis CMO Market Share by Players in 2023

Figure 15. Global Top Peptide Synthesis CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Synthesis CMO as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Peptide Synthesis CMO Revenue in 2023

Figure 17. North America Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Peptide Synthesis CMO Market Share by Country (2019-2030)

Figure 19. United States Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Peptide Synthesis CMO Market Share by Country (2019-2030)

Figure 23. Germany Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Peptide Synthesis CMO Market Share by Region (2019-2030)

Figure 31. China Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Peptide Synthesis CMO Market Share by Country (2019-2030)

Figure 39. Mexico Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Peptide Synthesis CMO Market Share by Country (2019-2030)

Figure 43. Turkey Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Peptide Synthesis CMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Bachem Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 46. PolyPeptide Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 47. USV Peptides Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 48. Thermofischer Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 49. Bio Basic Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 50. JPT Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 51. Genscript Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 52. Xinbang Pharma Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 53. ScinoPharm Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 54. AmbioPharm Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 55. SN Biopharm Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 56. CBL Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 57. Piramal Pharma Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 58. CordenPharma Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 59. CPC Scientific Revenue Growth Rate in Peptide Synthesis CMO Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’